Clinical trial
A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
NCT01773252 is registered in ClinicalTrials.gov with Cardiox Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A With-in Subject, Controlled Study to Determine the Sensitivity and Specificity of the Cardiox Flow Detection System for the Detection of Right-to-Left Cardiac Shunts Compared to Transesophageal Echocardiography and Transcranial Doppler Ultrasound
- Lead sponsor
- Cardiox Corporation
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- November 30, 2012
- Completion date
- November 30, 2015
- Enrollment
- 141 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
atrial septal defect, patent foramen ovale, right to left shunt